IRIS
CINELLI, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.803
NA - Nord America 1.610
EU - Europa 1.139
SA - Sud America 219
AF - Africa 38
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.813
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.558
SG - Singapore 838
RU - Federazione Russa 635
VN - Vietnam 356
CN - Cina 253
HK - Hong Kong 184
BR - Brasile 181
IT - Italia 132
DE - Germania 92
FR - Francia 70
NL - Olanda 61
IN - India 49
UA - Ucraina 30
GB - Regno Unito 28
JP - Giappone 26
FI - Finlandia 22
CA - Canada 19
MX - Messico 16
SE - Svezia 16
KR - Corea 15
BD - Bangladesh 14
ES - Italia 10
PL - Polonia 10
ZA - Sudafrica 10
BG - Bulgaria 9
TR - Turchia 9
VE - Venezuela 9
AR - Argentina 8
TH - Thailandia 8
CI - Costa d'Avorio 7
PH - Filippine 7
AT - Austria 6
CL - Cile 6
EC - Ecuador 6
ID - Indonesia 6
IQ - Iraq 6
PK - Pakistan 6
DO - Repubblica Dominicana 5
IE - Irlanda 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
LT - Lituania 4
SN - Senegal 4
CO - Colombia 3
CR - Costa Rica 3
KE - Kenya 3
NP - Nepal 3
PA - Panama 3
PY - Paraguay 3
TW - Taiwan 3
UY - Uruguay 3
UZ - Uzbekistan 3
AU - Australia 2
DZ - Algeria 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
AL - Albania 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GM - Gambi 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LB - Libano 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
SD - Sudan 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
Totale 4.813
Salva come PNG Salva come JPEG
Città #
Singapore 396
San Jose 317
Hong Kong 177
Moscow 162
Ashburn 149
Chandler 117
Beijing 101
Hanoi 94
Santa Clara 88
Ho Chi Minh City 85
Amsterdam 60
Napoli 52
Lauterbourg 46
Lawrence 44
Millbury 43
Des Moines 38
Los Angeles 38
The Dalles 38
Boston 31
Dallas 28
Redondo Beach 27
Hefei 21
Munich 21
Düsseldorf 20
Tokyo 20
Wilmington 20
New York 18
Frankfurt am Main 17
Naples 17
Da Nang 16
Buffalo 15
São Paulo 15
Brooklyn 14
Turku 14
Haiphong 12
Houston 12
Chicago 11
Orem 11
Rio de Janeiro 11
Seattle 11
Nuremberg 10
Fairfield 9
Atlanta 8
Can Tho 8
Guangzhou 8
Montreal 8
Denver 7
London 7
San Francisco 7
Sofia 7
Stockholm 7
Caracas 6
Helsinki 6
Hải Dương 6
Milan 6
Phoenix 6
Redwood City 6
Seoul 6
Warsaw 6
Washington 6
Woodbridge 6
Bhubaneswar 5
Bắc Giang 5
Falkenstein 5
Kochi 5
Mexico City 5
Asciano 4
Biên Hòa 4
Brasília 4
Chennai 4
Dakar 4
Guayaquil 4
Johannesburg 4
Miami 4
Nha Trang 4
Poplar 4
Santiago 4
Santo Domingo 4
Tianjin 4
Toronto 4
Afragola 3
Ankara 3
Aracaju 3
Asunción 3
Atibaia 3
Baghdad 3
Bangkok 3
Campinas 3
Charlotte 3
Dublin 3
Esslingen am Neckar 3
Fortaleza 3
Fremont 3
Gangnam-gu 3
Huế 3
Hyderabad 3
Karachi 3
Mumbai 3
Nairobi 3
Panama City 3
Totale 2.714
Salva come PNG Salva come JPEG
Nome #
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review 179
Erythrasmoid pityriasis versicolor with exclusive involvement of the pubis and inguinal region: report of two cases. 162
Efficacy and safety of risankizumab in psoriasis patients who failed anti‐IL‐17, anti‐12/23 and/or anti IL‐23: preliminary data of a real‐life 16‐week retrospective study 158
Endocrinological disorders and inflammatory skin diseases during COVID-19 outbreak: A review of the literature 152
Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data 143
A case of a primary cutaneous diffuse large B-cell lymphoma, leg type 142
Efficacy and safety of a new topical gel formulation containing retinol encapsulated in glycospheres and hydroxypinacolone retinoate, an antimicrobial peptide, salicylic acid, glycolic acid and niacinamide for the treatment of mild acne: preliminary results of a 2-month prospective study 140
QuantiFERON TB‐gold conversion rate among psoriasis patients under biologics: a 9‐year retrospective study 139
Apremilast efficacy and safety in elderly psoriasis patients over a 48-weeks period 135
A 15-year retrospective study on the prevalence of onychomycosis in psoriatic vs non-psoriatic patients: A new European shift from dermatophytes towards yeast. 129
16-year real-life study on the prevalence of mycoses in a paediatric population 129
Erythrodermic psoriasis successfully and rapidly treated with brodalumab: report of two cases 128
Hereditary Angioedema Type III, Recurrent Pregnancy Loss and Heterozygous MTHFR Mutation 127
Biologic Therapies, Psoriasis, and COVID-19: Our Experience at the Psoriasis Unit of the University of Naples Federico II 126
A case of Stewart-Treves Syndrome of the lower limbs: The usefulness of dermoscopy 124
A Case of Steatocystoma Multiplex in a Psoriatic Patient during Treatment with Anti-IL-12/23 123
Leg paralysis after photodynamic therapy for Lymphomatoid Papulosis: a case report 122
Anti‐interleukin‐23 for psoriasis in elderly: guselkumab, risankizumab and tildrakizumab in real world practice 118
Risankizumab in real life: preliminary results of efficacy and safety in psoriasis during a 16-week period 117
Efficacy and safety of ixekizumab in a group of 16 elderly patients with psoriasis over a 1‐year period 115
Efficacy and safety of guselkumab in psoriasis patients who failed ustekinumab and/or anti IL-17: a real-life 52-week retrospective study 115
Tinea Capitis in Campania: A 5-Year Retrospective Study in Childhood and Adolescence (2013-2018). 113
Real life efficacy and safety of secukinumab in elderly psoriasis patients over a 2-year period 109
Teledermatology for patient management, dermatology education and research during the COVID-19 pandemic 105
Mycoses in the elderly population: what a 16-year experience has taught us 104
A case of erythrodermic psoriasis successfully treated with apremilast 104
Dermoscopy and reflectance confocal microscopy of Kaposi's sarcoma: an overview 102
Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: A case series 101
Paracetamol-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient receiving apremilast therapy 100
Tildrakizumab: a new therapeutic option for erythrodermic psoriasis? 97
Chronic cutaneous ulcers management in dermatologic department during COVID-19 era 96
Hedgehog inhibitors in the treatment of advanced basal cell carcinoma: risks and benefits 95
Safe distance, safe patients! Therapeutic management of oncological patients affected by cutaneous and mucosal adverse events during the COVID-19 pandemic: an Italian experience 93
Trends in epidemiology of melanoma in situ in a center of South-Italy: Data from a melanoma reference center during the period 2004–2018 85
Treatment of pediatric psoriasis with TNF-antagonists: a real-life single-center case series 77
Retrospective analysis of skin toxicity in patients under anti-EGFR tyrosine kinase inhibitors: Our experience in lung cancer 73
Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature 72
Guselkumab in moderate to severe psoriasis in routine clinical care: an Italian 44-week real-life experience 71
Guselkumab and risankizumab for psoriasis: a 44-week indirect real-life comparison 68
Dietary Intervention: An Essential Part of the Management of Patients Affected by Hidradenitis Suppurativa 66
Ocular Manifestations in Psoriasis Screening (OcMaPS) Questionnaire: A Useful Tool to Reveal Misdiagnosed Ocular Involvement in Psoriasis 65
Real world practice indirect comparison between guselkumab and risankizumab: results from an Italian retrospective study 65
Profile of baricitinib and its potential in the treatment of moderate to severe atopic dermatitis: A short review on the emerging clinical evidence 60
Psoriasis awareness among general population: preliminary results of an online survey 59
Ixekizumab in scalp psoriasis: Clinical, dermoscopical, and in vivo reflectance confocal microscopy evaluation 54
Real-world experience versus clinical trials: pros and cons in psoriasis therapy evaluation 51
Totale 4.908
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.368
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.368
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022258 9 4 0 11 15 9 2 8 3 41 44 112
2022/2023301 46 30 12 11 34 31 0 18 37 55 22 5
2023/2024209 9 35 20 20 12 25 3 18 2 4 44 17
2024/20251.452 55 84 3 5 45 77 133 99 108 236 490 117
2025/20262.423 264 142 263 193 438 104 349 121 297 143 46 63
2026/202730 30 0 0 0 0 0 0 0 0 0 0 0
Totale 4.908